FONDS DE SOLIDARITE DES TRAVAILLEURS DU QUEBEC 4
4 · Milestone Pharmaceuticals Inc. · Filed May 15, 2019
Insider Transaction Report
Form 4
Transactions
- Conversion
Common Shares
2019-05-13+139,849→ 170,416 total - Conversion
Common Shares
2019-05-13+798,974→ 969,390 total - Conversion
Common Shares
2019-05-13+574,292→ 1,543,682 total - Conversion
Common Shares
2019-05-13+437,203→ 1,980,885 total - Conversion
Common Shares
2019-05-13+306,092→ 2,286,977 total - Purchase
Common Shares
2019-05-13$15.00/sh+433,333$6,499,995→ 2,720,310 total - Conversion
Series A-1 Preferred
2019-05-13−139,849→ 0 total→ Common Shares (139,849 underlying) - Conversion
Series A-2 Preferred
2019-05-13−798,974→ 0 total→ Common Shares (798,974 underlying) - Conversion
Series B Preferred
2019-05-13−574,292→ 0 total→ Common Shares (574,292 underlying) - Conversion
Series C Preferred
2019-05-13−437,203→ 0 total→ Common Shares (437,203 underlying) - Conversion
Series D-1 Preferred
2019-05-13−306,092→ 0 total→ Common Shares (306,092 underlying)
Footnotes (1)
- [F1]Each share of Class A-1 Preferred, Class A-2 Preferred, Class B Preferred, Class C Preferred and Class D-1 Preferred is convertible at any time, at the option of the holder, into Common Shares, on a one-for-one basis, has no expiration date and has converted into Common Shares upon the closing of the Issuer's initial public offering.